Neuroendocrine regulation of skin dendritic cells

Annals of the New York Academy of Sciences

Volumn 1088, Issue , 2006, Pages 195-206

  Seiffert, Kristina ^a   Granstein, Richard D ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antigen presentation; Catecholamine; Cytokines; Dendritic cell; Neuropeptide

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; NEUROPEPTIDE;

CELL FUNCTION; CELL MATURATION; CONFERENCE PAPER; DENDRITIC CELL; DOWN REGULATION; HOMEOSTASIS; IMMUNE RESPONSE; LANGERHANS CELL; NEUROENDOCRINE SYSTEM; SKIN INFLAMMATION; STIMULUS RESPONSE; ANIMAL; CYTOLOGY; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; NEUROSECRETION; REVIEW; SKIN;

ANIMALS; DENDRITIC CELLS; HUMANS; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; SKIN;

EID: 34447625541     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1366.011     Document Type: Conference Paper

References (48)

1. ANSEL, J.C. et al. 1997. Interactions of the skin and nervous system. J. Invest. Dermatol. Symp. Proc. 2: 23-26.
2. VALLADEAU, J. & S. SAELAND. 2005. Cutaneous dendritic cells. Semin. Immunol. 17: 273-283.
3. HOSOI, J. et al. 1993. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363: 159-163.
4. KODALI, S. et al. 2004. Vasoactive intestinal peptide modulates Langerhans cell immune function. J. Immunol. 173: 6082-6088.
5. KODALI, S. et al. 2003. Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function. Eur. J. Immunol. 33: 3070-3079.
6. MISERY, L. 1998. Langerhans cells in the neuro-immuno-cutaneous system. J. Neuroimmunol. 89: 83-87.
7. SEIFFERT, K. et al. 2002. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J. Immunol. 168: 6128-6135.
8. CHROUSOS, G.P. 2000. The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann. N. Y. Acad. Sci. 917: 38-67.
9. LUGER, T.A. 2002. Neuromediators-a crucial component of the skin immune system. J. Dermatol. Sci. 30: 87-93.
10. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N. Engl. J. Med. 332: 1351-1362.
11. CHROUSOS, G.P. & P.W. GOLD. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
12. ELENKOV, I.J. & G.P. CHROUSOS. 2002. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 966: 290-303.
13. CHROUSOS, G.P. 1998. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann. N. Y. Acad. Sci. 851: 311-335.
14. FELTEN, D.L. et al. 1985. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135: 755s-765s.
15. MADDEN, K.S., V.M. SANDERS & D.L. FELTEN. 1995. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35: 417-448.
16. CHU, D. et al. 2003. The stucture and development of the skin. In Dermatology in General Medicine. I. FREEDBERG, et al., Eds. McGraw-Hill New York..
17. SCHOLZEN, T. et al. 1998. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 7: 81-96.
18. LUGER, T.A. et al. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N. Y. Acad. Sci. 917: 232-238.
19. ABE, M. & A.W. THOMSON. 2003. Influence of immunosuppressive drugs on dendritic cells. Transpl. Immunol. 11: 357-365.
20. PAN, J. et al. 2001. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol. Lett. 76: 153-161.
21. ELENKOV, I.J., G.P. CHROUSOS & R.L. WILDER. 2000. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann. N. Y. Acad. Sci. 917: 94-105.
22. ASHWORTH, J., J. BOOKER & S.M. BREATHNACH. 1988. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br. J. Dermatol. 118: 457-469.
23. HOETZENECKER, W. et al. 2004. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J. Invest. Dermatol. 122: 673-684.
24. FELTEN, S.Y. et al. 1998. The role of the sympathetic nervous system in the modulation of immune responses. Adv. Pharmacol. 42: 583-587.
25. KOHM, A.P. & V.M. SANDERS. 2001. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53: 487-525.
26. ELENKOV, I.J. et al. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians. 108: 374-381.
27. PANINA-BORDIGNON, P. et al. 1997. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100: 1513-1519.
28. LANGENKAMP, A. et al. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1: 311-316.
29. MAESTRONI, G.J. 2002. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J. Neuroimmunol. 129: 106-114.
30. MAESTRONI, G.J. & P. MAZZOLA. 2003. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J. Neuroimmunol. 144: 91-99.
31. ELENKOV, I.J. et al. 2000. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52: 595-638.
32. MAESTRONI, G.J. 2000. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 165: 6743-6747.
33. DHABHAR, F.S. & B.S. MCEWEN. 1996. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156: 2608-2615.
34. DHABHAR, F.S. & B.S. MCEWEN. 1999. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96: 1059-1064.
35. FLINT, M.S. et al. 2001. Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge. J. Neuroimmunol. 113: 72-80.
36. HOSOI, J. et al. 1998. Modification of LC phenotype and suppression of contact hypersensitivity response by stress. J. Cutan. Med. Surg. 3: 79-84.
37. VISWANATHAN, K., C. DAUGHERTY & F.S. DHABHAR. 2005. Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity. Int. Immunol. 17: 1059-1069.
38. DHABHAR, F.S. & K. VISWANATHAN. 2005. Short-term stress experienced at time of immunization induces a long-lasting increase in immunologic memory. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R738-R744.
39. RIGGS, D.R. et al. 2002. In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin. J. Surg. Res. 108: 279-284.
40. SAINT-MEZARD, P. et al. 2003. Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J. Immunol. 171: 4073-4080.
41. GANEA, D., R. RODRIGUEZ & M. DELGADO. 2003. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Cell Mol. Biol. (Noisy-le-Grand) 49: 127-142.
42. DELGADO, M., E. GONZALEZ-REY & D. GANEA. 2005. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J. Immunol. 175: 7311-7324.
43. TORII, H. et al. 1997. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J. Leukoc. Biol. 61: 216-223.
44. TORII, H., K. TAMAKI & R.D. GRANSTEIN. 1998. The effect of neuropeptides/ hormones on Langerhans cells. J. Dermatol. Sci. 20: 21-28.
45. KITAZAWA, T. & J.W. STREILEIN. 2000. Hapten-specific tolerance promoted by calcitonin gene-related peptide. J. Invest. Dermatol. 115: 942-948.
46. LUGER, T.A. et al. 2003. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994: 133-140.
47. ANSEL, J.C. et al. 1996. Skin-nervous system interactions. J. Invest. Dermatol. 106: 198-204.
48. STANIEK, V. et al. 1997. Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch. Dermatol. Res. 289: 285-291.